JKS [JinkoSolar] CT ORDER:
[]
IDI [IDI] 6-K: (Original Filing)
[FORM 6-K November 15, 2010 SearchMedia Holdings Limited Cayman Islands (Jurisdiction of incorporation or organization) 15A Zhao Feng Universe Building x x n/a SearchMedia Holdings Limited Paul Conway Chief Executive Officer 6-K 1 htm_5416.htm LIVE FILING]
BORN [CHINA NEW BORUN] 6-K: (Original Filing)
[FORM 6-K China New Borun Corporation Bohai Industrial Park Yangkou Town Shouguang, Shandong Peoples Republic of China 262715 x Form 20-F o Form 40-F £ £ o Yes x No China New Borun Announces Third Quarter 2010 Financial Results 3Q10 Revenue Increased 26.1% Year-Over-Year 3Q10 Net Income Increased 17.9% Year-Over-Year Phase III Daqing Expansion on Track and on Schedule Beijing,]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[NEWS RELEASEystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 -mpany reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million - XIAN, CHINA November 16, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Third Quarter 2010 Highlights Revenuereases 45% YoY to record $18.5 million]
IDI [IDI] 6-K: FORM 6-K November 15, 2010 SearchMedia Holdings Limited
[FORM 6-K November 15, 2010 SearchMedia Holdings Limited Cayman Islands (Jurisdiction of incorporation or organization) 15A Zhao Feng Universe Building x x n/a SearchMedia Holdings Limited Paul Conway Chief Executive Officer 6-K 1 htm_5416.htm LIVE FILING]
BORN [CHINA NEW BORUN] 6-K: FORM 6-K China New Borun Corporation Bohai Industrial
[FORM 6-K China New Borun Corporation Bohai Industrial Park Yangkou Town Shouguang, Shandong Peoples Republic of China 262715 x Form 20-F o Form 40-F £ £ o Yes x No China New Borun Announces Third Quarter 2010 Financial Results 3Q10 Revenue Increased 26.1% Year-Over-Year 3Q10 Net Income Increased 17.9% Year-Over-Year Phase III Daqing Expansion on Track and on Schedule Beijing,]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Announces Record Organic Revenues of
[NEWS RELEASEystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 -mpany reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million - XIAN, CHINA November 16, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Third Quarter 2010 Highlights Revenuereases 45% YoY to record $18.5 million]
PWRD [Perfect World] 6-K: (Original Filing)
[Perfect World Co., Ltd. S ELVIN ING EE AU / Kelvin Wing Kee Lau Chief Financial Officer 2]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Reports Unaudited Third Quarter 2010 Financial Results - Conference call scheduled for Monday, November 15, 2010 at 8:00 AM EST Beijing November 15, 2010 Sinovac Biotech Ltd. ( NASDAQ: SVA), a leading provider of biopharmaceutical products in China , announc ed today its un audited financial results for the three-month and nine-month periods ended September 30,] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
WX [WuXi PharmaTech (Cayman)] SC 13D/A: (Original Filing)
[SCHEDULE 13D/A CUSIP No. Page 2 1 NAME OF REPORTING PERSONS Warburg Pincus Private Equity X, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) (b)]
